首页> 美国卫生研究院文献>Microbial Cell Factories >Expression of deleted atoxic atypical recombinant beta2 toxin in a baculovirus system and production of polyclonal and monoclonal antibodies
【2h】

Expression of deleted atoxic atypical recombinant beta2 toxin in a baculovirus system and production of polyclonal and monoclonal antibodies

机译:在杆状病毒系统中表达缺失的无毒的非典型重组β2毒素并产生多克隆抗体和单克隆抗体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background Clostridium perfringens is an important animal and human pathogen that can produce more than 16 different major and minor toxins. The beta-2 minor toxin (CPB2), comprising atypical and consensus variants, appears to be involved in both human and animal enterotoxaemia syndrome. The exact role of CPB2 in pathogenesis is poorly investigated, and its mechanism of action at the molecular level is still unknown because of the lack of specific reagents such as monoclonal antibodies against the CPB2 protein and/or the availability of a highly purified antigen. Previous studies have reported that purified wild-type or recombinant CPB2 toxin, expressed in a heterologous system, presented cytotoxic effects on human intestinal cell lines. Undoubtedly, for this reason, to date, these purified proteins have not yet been used for the production of monoclonal antibodies (MAbs). Recently, monoclonal antibodies against CPB2 were generated using peptides designed on predicted antigenic epitopes of this toxin.
机译:背景产气荚膜梭菌是一种重要的动物和人类病原体,可产生16种以上的主要和次要毒素。包含非典型和共有变体的beta-2次要毒素(CPB2)似乎与人类和动物肠毒素血症综合征有关。 CPB2在发病机理中的确切作用尚未得到充分研究,并且由于缺乏特异性试剂(例如针对CPB2蛋白的单克隆抗体)和/或高度纯化的抗原的可获得性,其在分子水平上的作用机理仍然未知。先前的研究报道,在异源系统中表达的纯化的野生型或重组CPB2毒素对人肠道细胞系具有细胞毒性作用。毫无疑问,由于这个原因,迄今为止,这些纯化的蛋白质尚未用于单克隆抗体(MAb)的生产。最近,使用在该毒素的预测抗原表位上设计的肽生成了针对CPB2的单克隆抗体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号